Literature DB >> 15658120

Experience with cervical stenosis and temporary paralysis in athletes.

Julian E Bailes1.   

Abstract

OBJECT: Transient spinal cord injury (TSCI) in athletes presents one of the most challenging clinical scenarios. Management difficulties in and subsequent return-to-play decisions are especially important in those with cervical canal stenosis.
METHODS: Ten athletes (nine male and one female patients) were evaluated for TSCI. The diagnostic survey included physical and neurological examinations, plain radiographs with flexion-extension dynamic studies, computerized tomography, and magnetic resonance (MR) imaging. Clinical courses were followed and, in those who returned to contact sports activities, subsequent experience was noted. Symptoms consisted of paralysis, weakness, or numbness in all four extremities, their duration ranging from 15 minutes to 48 hours. Radiography revealed no evidence of fracture/dislocation or ligamentous instability. Spinal stenosis of 8 to 13 mm in length at three or more levels was evident in all cases. Four patients returned to competition without recurrent TSCI (mean follow-up duration 40 months); six individuals retired. The occurrence of TSCI is not uncommon in athletes involved in contact sports. The diagnostic workup focuses on excluding fracture/dislocation, cord contusion, ligamentous infolding or instability, herniated nucleus pulposus, syrinx, or other surgically correctable lesions. There appear to be two groups of athletes who sustain TSCI: those who experience TSCI yet in whom radiographic studies are normal, and those with cervical stenosis, the most difficult management group.
CONCLUSIONS: It does not appear that a single episode of TSCI in an athlete with spinal stenosis will substantially increase the risk of subsequent catastrophic spinal cord injury in those in whom MR imaging demonstrates preservation of cerebrospinal fluid signal.

Entities:  

Mesh:

Year:  2005        PMID: 15658120     DOI: 10.3171/spi.2005.2.1.0011

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  8 in total

Review 1.  The pathomechanics, pathophysiology and prevention of cervical spinal cord and brachial plexus injuries in athletics.

Authors:  Simon Chao; Marisa J Pacella; Joseph S Torg
Journal:  Sports Med       Date:  2010-01-01       Impact factor: 11.136

2.  Evaluation of the anatomical and functional consequences of repetitive mild cervical contusion using a model of spinal concussion.

Authors:  Ying Jin; Julien Bouyer; Christopher Haas; Itzhak Fischer
Journal:  Exp Neurol       Date:  2015-06-10       Impact factor: 5.330

Review 3.  Trauma to the ankylotic spine: imaging spectrum of vertebral and soft tissue injuries.

Authors:  Aldo Gonzalez-Beicos; Diego B Nuñez; Alice W Fung; Maria Sanchez; Helmuth Gahbauer
Journal:  Emerg Radiol       Date:  2007-09-18

4.  Degenerative cervical spinal stenosis: current strategies in diagnosis and treatment.

Authors:  Frerk Meyer; Wolfgang Börm; Claudius Thomé
Journal:  Dtsch Arztebl Int       Date:  2008-05-16       Impact factor: 5.594

Review 5.  Management of cervical spine injuries in athletes.

Authors:  Julian E Bailes; Meredith Petschauer; Kevin M Guskiewicz; Gary Marano
Journal:  J Athl Train       Date:  2007 Jan-Mar       Impact factor: 2.860

6.  Return to Play after Cervical Spine Injuries: A Consensus of Opinion.

Authors:  John C France; Michael Karsy; James S Harrop; Andrew T Dailey
Journal:  Global Spine J       Date:  2016-04-12

7.  Does a Syrinx Matter for Return to Play in Contact Sports? A Case Report and Evidence-Based Review of Return-to-Play Criteria After Transient Quadriplegia.

Authors:  Jeffrey L Milles; Michael A Gallizzi; Seth L Sherman; Patrick A Smith; Theodore J Choma
Journal:  Sports Health       Date:  2014-09       Impact factor: 3.843

8.  Prevalence of spine degeneration diagnosis by type, age, gender, and obesity using Medicare data.

Authors:  Chantal S Parenteau; Edmund C Lau; Ian C Campbell; Amy Courtney
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.